Article
Messenger Ribonucleic Acid (mRNA)-Based Universal Vaccines: Engineering Broad-Spectrum Immunity Against Future Pandemics
26 May 2025
Abstract excerpt
The rapid emergence and evolution of infectious pathogens, including the COVID-19 pandemic and recurring influenza outbreaks, underscore the need for universal vaccines capable of providing broad-spectrum immunity. Messenger ribonucleic acid (mRNA) vaccine technology has emerged as a transformative platform due to its rapid development, high immunogenicity, and adaptability to new variants. Unlike conventional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
